tirzepatide torrance Torrance Medical Weight Loss Clinic

Unlike many traditional treatments, tirzepatide targets multiple metabolic pathways, harnessing its potential to influence body weight through various mechanisms

Zyromski et al., 2009

In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%

In December 2025, federal courts consolidated 80 lawsuits alleging child sexual abuse and exploitation on the Roblox platform

Presented for research literature review only Shetty NP et al

Treatment shaped around your skin